GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (LTS:0A87) » Definitions » Total Operating Expense

Takeda Pharmaceutical Co (LTS:0A87) Total Operating Expense : $17,023 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Takeda Pharmaceutical Co Total Operating Expense?

Takeda Pharmaceutical Co's Total Operating Expense for the three months ended in Sep. 2024 was $3,554 Mil. Takeda Pharmaceutical Co's Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was $17,023 Mil.

Takeda Pharmaceutical Co Total Operating Expense Historical Data

The historical data trend for Takeda Pharmaceutical Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Total Operating Expense Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,783.38 16,430.23 16,159.21 16,672.51 16,794.52

Takeda Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,065.10 5,506.17 3,815.00 4,147.40 3,554.21

Takeda Pharmaceutical Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $17,023 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Takeda Pharmaceutical Co Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (LTS:0A87) » Definitions » Total Operating Expense
Comparable Companies
TSE:4523 TSE:4507 TSE:4581 TSE:4516 TSE:4530 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4521 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA XSWX:SDZ VTRS NBIX SZSE:000538 NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
TAK:USA TKPHF:USA 4502:Japan TKDA:Germany TAKP34:Brazil TKD:Austria
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Website
https://www.takeda.com
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines